MMP-3 Inhibitor

CAS No. 158841-76-0

MMP-3 Inhibitor( —— )

Catalog No. M34905 CAS No. 158841-76-0

MMP-3 Inhibitor is a peptide matrix metalloproteinase-3 (MMP-3) inhibitor with a Ki value of 95 nM.MMP-3 inhibitor has anticancer and antitumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 221 In Stock
5MG 208 In Stock
10MG 310 In Stock
25MG 525 In Stock
50MG 741 In Stock
100MG 1014 In Stock
200MG Get Quote In Stock
500MG 2065 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MMP-3 Inhibitor
  • Note
    Research use only, not for human use.
  • Brief Description
    MMP-3 Inhibitor is a peptide matrix metalloproteinase-3 (MMP-3) inhibitor with a Ki value of 95 nM.MMP-3 inhibitor has anticancer and antitumor activity.
  • Description
    MMP3 inhibitor 3 is an inhibitor of MMP3. MMP3 inhibitor 3 can used to study breast cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MMP
  • Recptor
    MMP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    158841-76-0
  • Formula Weight
    686.78
  • Molecular Formula
    C27H46N10O9S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C([C@@H](NC(CNC([C@@H](NC([C@H](CCCNC(=N)N)NC(C)=O)=O)CS)=O)=O)[C@H](C)C)(=O)N1[C@H](C(N[C@@H](CC(O)=O)C(N)=O)=O)CCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Holliday DL, et al. Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion. Breast Cancer Res. 2007;9(5):R67.?
molnova catalog
related products
  • Dehydroeffusol

    Dehydroeffusol possesses anti-cancer, anxiolytic and sedative properties. Dehydroeffusol inhibits gastric cancer cell growth and tumorigenicity by selectively inducing tumor-suppressive endoplasmic reticulum stress and a moderate apoptosis.

  • CTTHWGFTLC, CYCLIC

    This cyclic CTT Gelatinase Inhibitor peptide is an inhibitor for matrix metalloproteinases (MMP)-2 and MMP-9. It is also called type IV collagenase or gelatinase. Gelatinases are potential targets of therapeutic intervention in cancer, and inhibitors of these enzymes can prevent tumor progression.

  • Andecaliximab

    Andecaliximab is a recombinant IgG4 monoclonal antibody targeting matrix metalloproteinase 9 (MMP9). Andecaliximab showed antifibrotic effects in a mouse model of idiopathic pulmonary fibrosis.